Illumina Inc.
ILMN
NGS
Sector: Healthcare
Industry: Diagnostics & Research
187.24
USD
-3.55
(-1.86%)
Optionable: Yes Market Cap: 29,390 M 90-day average vol: 1,594,199
Previous close: 190.79 Open: 193.82 Bid: 191.01 Ask: 191.01
52 week range
173.45 428.00
Last updated: Tuesday 4th October 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 6.26 |
Price per Book TTM ($) | 2.77 |
PE Ratio (TTM) | -2,045.80 |
Book Value per Share ($) | 67.77 |
5 Year PE Range | 44.1 , 54.8 |
Returns
7 Day Return | 1.69% | |
1 Month Return | -6.86% | |
3 Month Return | -2.99% | |
1 Year Return | -50.71% | |
3 Year Return | -38.07% | |
5 Year Return | -9.01% | |
YTD Return | -50.78% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 41.89 |
14 Day SMA ($) | 194.17 |
14 Day EMA ($) | 194.31 |
Money Flow Index | 70.15 |
Average True Range | 10.44 |
50 Day SMA ($) | 206.15 |
200 Day SMA ($) | 275.97 |
ADX | 12.40 |
MACD | -4.35 |
Growth
Free Cash Flow QoQ Growth | -51.35% |
Free Cash Flow YoY Growth | -62.18% |
Revenue YoY Growth | 39.73% |
EPS QoQ Growth | -718.18% |
Revenue QoQ Growth | -4.99% |
EPS YoY Growth | 13.17% |
Profitability
News
Financials
ILMN Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1,149 M | 1,421 M | 1,861 M | 2,220 M | 2,398 M | 2,752 M | 3,333 M | 3,543 M | 3,239 M | 4,526 M |
| Cost of sales | 310 M | 411 M | 451 M | 544 M | 591 M | 770 M | 854 M | 888 M | 849 M | 1,121 M |
| Gross operating profit | 774 M | 912 M | 1,298 M | 1,549 M | 1,666 M | 1,826 M | 2,300 M | 2,467 M | 2,203 M | 3,154 M |
| Selling Gen & administrative expense | 286 M | 381 M | 466 M | 516 M | 584 M | 674 M | 794 M | 835 M | 941 M | 2,092 M |
| Research & development expense | 231 M | 277 M | 388 M | 401 M | 504 M | 546 M | 623 M | 647 M | 682 M | 1,185 M |
| Operating income | 257 M | 254 M | 443 M | 632 M | 578 M | 606 M | 883 M | 985 M | 580 M | -123 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -12 M | -60 M | 43 M | -11 M | 6 M | 455 M | 24 M | 110 M | 284 M | 1,068 M |
| Pre-tax Income (EBT) | 223 M | 159 M | 449 M | 583 M | 561 M | 1,043 M | 894 M | 1,118 M | 856 M | 884 M |
| Income taxes | 71 M | 34 M | 95 M | 125 M | 133 M | 365 M | 112 M | 128 M | 200 M | 122 M |
| Net income from total operations | 151 M | 125 M | 353 M | 458 M | 428 M | 678 M | 782 M | 990 M | 656 M | 762 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | 151 M | 125 M | 353 M | 462 M | 463 M | 726 M | 826 M | 1,002 M | 656 M | 762 M |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | 151 M | 125 M | 353 M | 458 M | 428 M | 678 M | 782 M | 990 M | 656 M | 762 M |
| Depreciation | 65 M | 98 M | 113 M | 127 M | 141 M | 156 M | 179 M | 188 M | 187 M | 251 M |
| Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income before depreciation (EBITDA) | 326 M | 297 M | 603 M | 753 M | 735 M | 1,236 M | 1,130 M | 1,358 M | 1,092 M | 1,196 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | 1.23 | 1 | 2.61 | 3.19 | 3.09 | 4.96 | 5.63 | 6.81 | 4.48 | 5.07 |
| Diluted EPS total | 1.13 | 0.9 | 2.37 | 3.1 | 3.07 | 4.92 | 5.56 | 6.74 | 4.45 | 5.04 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today